KS

Karen Spilizewski

Managing Director at RiverVest Venture Partners

Cleveland, Ohio

Overview 

Karen Spilizewski is the Managing Director at RiverVest Venture Partners in Cleveland, Ohio, with a background in biomedical engineering and venture capital. She has successfully led investments in various stages and sectors, such as Series A and B in medical devices and biotech companies, and has held key roles in companies like Standard Bariatrics and BioEnterprise. Karen's career highlights include her leadership in new business development and her expertise in due diligence and commercialization, contributing to the growth and success of startups in the Midwest region.

Work Experience 

  • Managing Director

    2023 - Current

  • Vice President

    2008 - 2023

    RiverVest is a venture capital firm that invests in early stage medical device and pharma/biotech companies.

  • Member Board Of Directors

    2018 - 2022

    Standard Bariatrics is a Medical Device company focused in reducing variation in Sleeve Gastrectomy, improving patient outcomes and increasing OR efficiency.

Standard Bariatrics is a medical device company that develops and offers surgical instruments for weight-loss surgeries.

Raised $63,160,000.00 from Silicon Valley Bank.

  • Vice President, Business Development

    2005 - 2020

    Identifies, assesses and accelerates emerging medical device companies originating from regional university/clinical research, local entrepreneurs, or companies relocating to the Cleveland area. With more than 20 years of experience in growth technologies and investments, provides client companies strategic direction, funding guidance and product development expertise.

BioEnterprise is a business formation, recruitment, and acceleration initiative designed to grow health care companies and commercialize

  • Member Board Of Directors

    2011 - 2018

    Securus Medical is developing state of the art tissue temperature monitoring and mapping systems. The technology has utility in various critical care applications where more comprehensive monitoring is desired.

  • Board Observer

    2011 - 2017

    Neuros's patented platform technology, Electrical Nerve Block, is focused on elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post surgical pain, and chronic migraine.

Neuros Medical develops neurostimulation therapies for patients suffering with unmet medical needs.

Raised $113,740,458.00 from Trinity Capital.

  • Business Development Manager

    1986 - 2005

Avery Dennison is a company focusing on labeling and packaging materials and solutions.

Raised $942,875,787.00.

Articles About Karen

Relevant Websites